US20020119075A1 - Apparatus and process for concentrating a liquid sterilant and sterilizing articles therewith - Google Patents

Apparatus and process for concentrating a liquid sterilant and sterilizing articles therewith Download PDF

Info

Publication number
US20020119075A1
US20020119075A1 US09/975,714 US97571401A US2002119075A1 US 20020119075 A1 US20020119075 A1 US 20020119075A1 US 97571401 A US97571401 A US 97571401A US 2002119075 A1 US2002119075 A1 US 2002119075A1
Authority
US
United States
Prior art keywords
chamber
solution
hydrogen peroxide
water
vapor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US09/975,714
Inventor
Paul Jacobs
Suz-Min Lin
Jenn-Hann Wang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22836677&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=US20020119075(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Individual filed Critical Individual
Priority to US09/975,714 priority Critical patent/US20020119075A1/en
Publication of US20020119075A1 publication Critical patent/US20020119075A1/en
Priority to US10/403,140 priority patent/US7252800B2/en
Priority to US10/764,861 priority patent/US20040170527A1/en
Priority to US11/093,526 priority patent/US7670550B2/en
Priority to US11/414,003 priority patent/US20070014691A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/16Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
    • A61L2/20Gaseous substances, e.g. vapours
    • A61L2/208Hydrogen peroxide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/02Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
    • A61L2/14Plasma, i.e. ionised gases
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/16Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/26Accessories or devices or components used for biocidal treatment
    • A61L2/28Devices for testing the effectiveness or completeness of sterilisation, e.g. indicators which change colour
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2202/00Aspects relating to methods or apparatus for disinfecting or sterilising materials or objects
    • A61L2202/10Apparatus features
    • A61L2202/12Apparatus for isolating biocidal substances from the environment
    • A61L2202/122Chambers for sterilisation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2202/00Aspects relating to methods or apparatus for disinfecting or sterilising materials or objects
    • A61L2202/20Targets to be treated
    • A61L2202/24Medical instruments, e.g. endoscopes, catheters, sharps

Definitions

  • the present invention relates to a process for sterilization of medical instruments using a liquid sterilant. More particularly, the invention relates to a process in which sterilization is achieved by concentrating a liquid sterilant such as hydrogen peroxide solution inside of a sterilization chamber and sterilizing articles therewith.
  • a liquid sterilant such as hydrogen peroxide solution inside of a sterilization chamber and sterilizing articles therewith.
  • the hydrogen peroxide for each sterilization cycle is shipped to the location of the sterilization system, generally by air or ground transportation.
  • premeasured amounts of a hydrogen peroxide and water solution are provided in sealed enclosure, such as a capsule inside of a cassette housing which can be automatically opened by the system to reduce contact between the system user and the hydrogen peroxide solution.
  • sealed enclosure such as a capsule inside of a cassette housing which can be automatically opened by the system to reduce contact between the system user and the hydrogen peroxide solution.
  • U.S. Pat. No. 4,952,370 discloses a sterilization process in which aqueous hydrogen peroxide vapor is first condensed on the article to be sterilized, followed by application of a vacuum to the sterilization chamber to remove the water and hydrogen peroxide from the article.
  • This method is suitable for surface sterilization, but not for sterilization of diffusion-restricted areas such as long narrow lumens because it depends on the diffusion of hydrogen peroxide vapor into the lumen to effect sterilization.
  • U.S. Pat. No. 4,943,414 discloses a process in which a vessel containing a small amount of a vaporizable liquid sterilant solution is attached to a lumen, and the sterilant vaporizes and flows directly into the lumen of the article as the pressure is reduced during the sterilization cycle.
  • This system has the advantage that the water and hydrogen peroxide vapor are pulled through the lumen by the existing pressure differential, increasing the sterilization rate for lumens, but has the disadvantage that the vessel needs to be attached to each lumen to be sterilized. In addition, water is vaporized faster and precedes the hydrogen peroxide vapor into the lumen.
  • FIG. 1 is a schematic diagram of a chamber and accessories suitable for use in the hydrogen peroxide sterilization process of the invention.
  • FIG. 2 is a schematic diagram of a chamber, pump and throttle valve for use in the hydrogen peroxide sterilization process of the invention.
  • FIG. 3 is a schematic diagram of a system with one pump and two valves, one valve having a larger pump vacuum line for quicker pumpdown and one having a smaller vacuum line for slower pumpdown.
  • FIG. 4 is a schematic diagram of a single valve sterilization system having two pumps, one for slower pumpdown and one for quicker pumpdown.
  • FIG. 5 is a schematic diagram of a system with two pumps and two valves, one pump for slower pumpdown and one for quicker pumpdown.
  • FIG. 6 is a schematic diagram of a system with a vaporizer.
  • FIG. 7 is a schematic diagram of a system with an alternative vaporizer.
  • FIG. 8 is a schematic diagram of a system with a further alternative vaporizer.
  • FIGS. 1 and 2 An apparatus useful in the process of the present invention is shown schematically in FIGS. 1 and 2 and comprises a chamber 2 , a throttle valve 4 and a pump 6 .
  • the chamber 2 is attached to the pump 6 by the throttle valve 4 .
  • the valve 4 can be controlled either automatically or manually to maintain the pressure.
  • the throttle valve 4 opens based on the pressure in the chamber via a pressure transducer and valve controller.
  • Such valves are commercially available from, for example, MKS (Andover, Md.).
  • Hydrogen peroxide can be introduced into the system in any fashion.
  • a dilute, aqueous solution of hydrogen peroxide is placed in wells 8 as shown in FIG. 1.
  • the aqueous solution of hydrogen peroxide can also be placed within the lumen of long narrow objects to be sterilized.
  • the hydrogen peroxide vaporizes and contacts the surface to be sterilized (i.e., colonoscope 10 in FIG. 1) which is placed on metal grid 12 which rests on tray 14 .
  • the tray can be configured with a plurality of wells designed to retain a known volume of liquid sterilant.
  • the volume of sterilization chamber 2 is about 18.5 liters and its dimensions are about 22′′ (55.9 cm) ⁇ 4.25′′ (10.8 cm) ⁇ 12′′ (30.5 cm).
  • FIG. 3 illustrates a parallel two-valve arrangement for use in the sterilization process of the invention.
  • the chamber 2 is in fluid communication with the pump 6 via valves 16 and 18 .
  • Valve 16 mediates the initial rapid evacuation, the first step of a two step evacuation process.
  • Valve 18 mediates slow evacuation, the second step of the process, which ensures maximal contact of the article to be sterilized with the vaporized aqueous hydrogen peroxide.
  • the pumpdown rate can be controlled by the pumping speed and/or the percent opening of the valve. Either valve can be used to maintain the pressure.
  • FIG. 4 illustrates a sterilization apparatus having two pumps 20 and 22 , and one valve 4 .
  • Pump 20 allows quicker pumpdown of the chamber 2
  • pump 22 allows slower pumpdown.
  • FIG. 5 illustrates an alternate configuration having two valves 24 and 26 in fluid communication with the pumps 20 and 22 , respectively.
  • hydrogen peroxide can be introduced into the chamber as a liquid.
  • hydrogen peroxide is introduced as a vapor and the chamber parameters are changed so that the vapor condenses as a liquid on the surface of interior of an article to be sterilized. Such changes include increasing the pressure.
  • the aqueous solutions of hydrogen peroxide can be relatively dilute, e.g. as low as 1-6% peroxide by weight, since sterilization is not achieved through contact with the hydrogen peroxide solution, but rather is achieved at low temperatures (preferably 15°-80° C., more preferably 20°-60° C., still more preferably 40°-55° C.) and in short periods of time (preferably less than one hour, and more preferably less than one-half hour) upon exposure to hydrogen peroxide under vacuum.
  • the method of the present invention is particularly effective with articles having inaccessible or hard-to-reach places. Such articles include long, narrow lumens, hinges and other articles having spaces where diffusion of vapors is restricted.
  • liquid sterilants which have vapor pressures lower than the vapor pressure of the solvent in which they are provided are also contemplated.
  • sterilants include, for example, aqueous peracetic acid solution and aqueous glutaraldehyde solution.
  • the article to be sterilized is contacted with sterilant prior to the vaporization step to localize at least some of the vaporization in the diffusion restricted areas.
  • Such contacting can be accomplished either directly or indirectly.
  • Direct contacting includes methods such as static soaking, flow through, aerosol spray, condensation of a vapor. Any other methods involving physically contacting the articles to be sterilized with sterilant would be considered direct contacting.
  • Indirect contacting includes those methods in which sterilant is introduced into the chamber, but not directly on or in the articles to be sterilized.
  • deep vacuum can be used to remove residual sterilant.
  • a plasma can also be used to both enhance sterilization efficacy and to remove residual sterilant.
  • the pumps shown schematically in the figures can be any commercially available pump.
  • the Leybold pump can reach a pressure of less than 0.1 torr and the KNF pump can reach a pressure of less than 10 torr.
  • excess hydrogen peroxide in the system may leave a residual which is difficult to remove.
  • the vapor concentration of hydrogen peroxide is preferably kept below 30 mg/l, more preferably less than 20 mg/l, and more preferably still less than 15 mg/l. If higher vapor concentrations of hydrogen peroxide are desired, excess residual can be removed using a gas plasma.
  • substrates such as stainless steel, polyethylene or polypropylene, which do not retain a residual, there is no reason to limit to the amount of peroxide which can be present in the vapor phase in the system during sterilization.
  • the chamber 2 may be dried prior to the introduction of hydrogen peroxide.
  • Many means may be employed to drive water out of the chamber. Primarily, this is accomplished by vaporizing the water and pumping it out of the chamber. The vaporization can be accomplished with heat, plasma induction, vacuum or the like, either alone or in combination. Merely drawing a vacuum prior to introducing the hydrogen peroxide accomplishes a benficial drying of the chamber 2 . If the chamber 2 is heated during this process and if a high energy electromagnetic field is applied to urge the water into the plasma stage the drying is enhanced.
  • U.S. Pat. No. 5,656,238 issued on Aug. 12, 1997 to Spencer at al. and incorporated herein by reference teaches such techniques in more detail.
  • FIGS. 6 to 8 show several new preferred methods.
  • a chamber 30 is evacuated by a pump 32 separated from the chamber 30 by a throttle valve 34 .
  • a vaporizer 36 comprises a housing 38 in fluid communication with the chamber 30 and into which extends a liquid feeding nozzle 40 from outside of the chamber 32 .
  • a cup 42 within the housing 38 receives hydrogen peroxide from the nozzle 40 .
  • the hydrogen peroxide can be vaporized as it exits the nozzle 40 , or more preferably in a controlled fashion from the cup 42 by controlling the temperature of the cup 42 and the pressure in the chamber 30 .
  • Temperature control of the cup 42 can be as simple as thermally isolating it from the chamber 30 , or a more active control system can be employed such a cooling coil or the like to maintain the cup 42 at a desired low temperature.
  • the entire vaporizer 36 is thermally isolated from the chamber 30 or temperature controlled in some fashion. Lower temperatures of vaporization enhance the preferential vaporization of water by exploiting the larger difference between the vapor pressures of water and hydrogen peroxide at lower temperatures.
  • Creating a diffusion restriction 44 between the vaporizer 36 and chamber 30 enhances the preferential extraction of water vapor from the chamber as water vapor will more easily traverse the diffusion restriction and be pumped out of the chamber during the vaporization process.
  • the diffusion restriction 44 may be simply reducing the clearance between the cup 42 and housing 38 through with the vapor must travel to reach the chamber 30 .
  • FIG. 7 shows a similar chamber 50 , pump 52 and valve 54 with modified vaporizer 56 .
  • the vaporizer 56 comprises a chamber 58 separated from the chamber 50 by a diffusion restriction 60 , such as a permeable membrane. Liquid hydrogen peroxide solution enters the chamber 58 through a valve 62 .
  • FIG. 8 illustrates a similar arrangement with a chamber 70 , pump 72 , valve 74 , and vaporizer 76 with a chamber 78 and valved hydrogen peroxide solution inlet 80 . Restriction of the diffusion between the vaporizer chamber 78 and main chamber 70 is variable. During initial vaporization when primarily water is vaporizing the vapors pass through a tight diffusion restriction 82 . After the concentration of the hydrogen peroxide solution reaches a given level a valve 84 may be opened to speed the vaporization and diffusion of the concentrated hydrogen peroxide solution.
  • the temperature in the chamber is no less than 5° C. nor more than 150° C., with the range of 50 to 65° C. being preferred, and the pressure should be no less than 0.01 torr, nor typically greater than atmosphere during the process, with the lowest vacuum being typically 0.4 torr and the diffusion pressure preferably being between 2 and 10 torr, although other conditions within the spirit of the invention will be apparent to those of skill in the art.
  • the pressure should not fall below 0.5 torr. Shorter overall cycles are preferred for convenience, with 5 minutes being a desirable goal, but longer times upwards of 6 hours or more may be warranted in some circumstances.
  • Tables 1 and 2 illustrate the effectiveness of the present invention.
  • the experiments were run on a chamber of 73 liters at 45° C. with 1780 mg of hydrogen peroxide 59% solution.
  • the diffuser is separated from the chamber by 12 2 mm diameter holes to effect diffusion restriction.
  • an automated control system preferably employing a computer processer, recieves inputs of the temperature, pressure and perhaps also the hydrogen peroxide concentration and calculates the optimal pressure at which to maintain the chamber to remove the water from the hydrogen peroxide solution and from the chamber 30 . It can also determine when the solution is sufficiently concentrated. For instance, it may be desired to only concentrate the solution to a certain degree so as to minimize the loss of hydrogen peroxide from the chamber, thereby minimizing hydrogen peroxide emissions from the chamber. While preferentially vaporizing the water from the solution, some hydrogen peroxide will also vaporize.
  • the valve 34 can be controlled to remove the vapor until the desired ratio is achieved.
  • the ratio can be determined using a hydrogen peroxide monitor and a moisture monitor, or by using a hydrogen peroxide monitor and a pressure sensor and then calculating the water using the PVRT equation and making the assumption that water and peroxide are essentially the only gases within the chamber 34 .
  • Table 3 illustrates the effects of the ratio of hydrogen peroxide vapor to water vapor in the chamber 30 on the ability to sterilize long narrow lumens or other diffusion restricted environments. Water vapor was first introduced into the system and then essentially pure hydrogen peroxide vapor was introduced by liberation from a solid form. The lower concentrations of water show no failures, whereas with the higher ratio in the last column the efficacy decreased and in one test 3 out of 3 samples failed.
  • Table 4 shows similar results by comparing a sterilization process in which the concentration of hydrogen peroxide is not increased according to the present invention with a process in which it is increased.
  • Table 5 shows the degree of concentration achieved according to the present invention. By monitoring the concentration (i.e.
  • the process may be further enhanced by admitting sufficient hydrogen peroxide into the system so as to force some of the vaporized solution to condense upon the instruments being sterilized within the system.
  • the solution can be vaporized by admitting it into the system at any pressure above the vapor pressures of water and hydrogen peroxide in the solution and then vaporized by reducing the pressure, or by admitting the solution at a pressure substantially below these vapor pressures whereupon it will start to vaporize thus releasing gas and increasing the pressure.
  • the pressure is then further reduced by pumping the concentration of the hydrogen peroxide in the system can be increased.
  • a typical cycle might comprise placing a load of instruments (not shown) within a CSR wrapped tray within the chamber 30 and then drawing a vacuum on the chamber 30 with the pump 32 down to below 1 torr or about 0.4 torr.
  • An electromagnetic field applied to the chamber 30 at such time tends to drive any remaining water into the vapor or plasma stage so that it can be removed by the pump 32 .
  • the pump 32 can be cycled or merely run continuously with the valve 34 controlling the vacuum process. Fresh dry air may be admitted to the chamber 30 including raising of the pressure back to atmosphere.
  • the hydrogen peroxide solution preferably a 59% hydrogen peroxide solution
  • the pump 32 exhausts the chamber 30 to a level at which the solution begins to vaporize.
  • a monitor 100 for hydrogen peroxide vapor and monitor 102 (see FIG. 6) for water vapor in connection with an automated control system 104 can be employed to optimize the pressure conditions to enhance the initial vaporization and exhaust of water vapor.
  • the pressure in the chamber 30 can be further lowered to vaporize the remaining solution.
  • the valve 32 is closed to isolate the chamber 30 , and the vaporized hydrogen peroxide solution is allowed to diffuse throughout the chamber to contact the instruments.
  • Additional dry air or other gas can be admitted at this time to help push the sterizing vapors into diffusion restricted areas, with the chamber 30 then further exhausted to resume a vacuum in the range of 2 to 10 torr. Additional admissions of air and vacuum can be employed, especially in connection with additional admission and concentration of hydrogen peroxide solutions.
  • aan electromagnetic field may be applied to drive the vapor into the plasma stage and effect further steilization. When the field is removed the ions formed from the hydrogen peroxide recombine as water and oxygen, leaving little residual hydrogen peroxide.
  • the chamber can be raised to atmospheric pressure and the load removed.

Abstract

A method for sterilizing a device, includes the following steps: contacting the device with liquid sterilant outside or inside a sterilization chamber at a first pressure, placing the device in the chamber before or after the contacting step, and decreasing the pressure of the chamber to a second pressure below the vapor pressure of the liquid sterilant. At least the decrease in pressure below about the vapor pressure of the liquid sterilant occurs at a pumpdown rate of less than 0.8 liters per second, calculated based on the time required to evacuate the chamber from atmospheric pressure to 20 torr when the chamber is empty and dry.

Description

    FIELD OF THE INVENTION
  • The present invention relates to a process for sterilization of medical instruments using a liquid sterilant. More particularly, the invention relates to a process in which sterilization is achieved by concentrating a liquid sterilant such as hydrogen peroxide solution inside of a sterilization chamber and sterilizing articles therewith. [0001]
  • BACKGROUND OF THE INVENTION
  • Medical instruments have traditionally been sterilized using either heat, such as is provided by steam, or a chemical, such as formaldehyde or ethylene oxide in the gas or vapor state. Each of these methods has its drawbacks. Many medical devices such as fiberoptic devices, endoscopes, power tools, etc., are sensitive to heat, moisture or both. Formaldehyde and ethylene oxide are both toxic gases that pose a potential hazard to healthcare workers. Problems with ethylene oxide are particularly severe, because its use requires long aeration times to remove the gas from articles that have been sterilized. This lengthens the sterilization cycle time undesirably. [0002]
  • Sterilization using liquid hydrogen peroxide solution has been found to require high concentrations of sterilant, extended exposure time and/or elevated temperatures. However, sterilization using hydrogen peroxide vapor has been shown to have some advantages over other chemical sterilization processes (see, e.g., U.S. Pat. Nos. 4,169,123 and 4,169,124 which are incorporated herein by reference). The combination of hydrogen peroxide with a plasma provides certain additional advantages, as disclosed in U.S. Pat. No. 4,643,876 which is incorporated herein by reference. Commercially available sterilization devices, such as the STERRAD® sterilization systems sold by Advanced Sterilization Systems division of Ethicon, Inc. automate the process of injecting a solution of hydrogen peroxide into a sterilization chamber, vaporizing the solution to provide a hydrogen peroxide vapor, contacting articles to be sterilized with the vapor, and exciting the vapor into the plasma stage. The hydrogen peroxide for each sterilization cycle is shipped to the location of the sterilization system, generally by air or ground transportation. Preferably, as in the case with the STERRAD® brand systems, premeasured amounts of a hydrogen peroxide and water solution are provided in sealed enclosure, such as a capsule inside of a cassette housing which can be automatically opened by the system to reduce contact between the system user and the hydrogen peroxide solution. Such cassettes are described more fully in U.S. Pat. Nos. 4,817,800 and 4,899,519 incorporated herein by reference. [0003]
  • The sterilization of articles containing diffusion-restricted areas, such as long narrow lumens, presents a special challenge. Methods that use hydrogen peroxide vapor that has been generated from an aqueous solution of hydrogen peroxide have certain disadvantages. One disadvantage is that because water has a higher vapor pressure than hydrogen peroxide, it will vaporize faster. Another disadvantage is that because of its lower molecular weight, water will diffuse faster than hydrogen peroxide in the vapor state. Because of these physical properties, when an aqueous solution of hydrogen peroxide is vaporized in the area surrounding the items to be sterilized, the water reaches the items first and in higher concentration. The water vapor inhibits penetration of hydrogen peroxide vapor into diffusion-restricted areas, such as small crevices and long narrow lumens. Simply employing a more concentrated solution of hydrogen peroxide fails to adequately address the problem due to the difficulty in handling highly concentrated hydrogen peroxide solutions. Transportation of such solutions can be particularly difficult. In general, such solutions are limited to concentrations of less than 60% hydrogen peroxide, however, regulations and the like regarding such concentrations may of course be modified in the future. In any event, shipping and handling of highly concentrated solutions remains impractical. [0004]
  • U.S. Pat. No. 4,952,370 discloses a sterilization process in which aqueous hydrogen peroxide vapor is first condensed on the article to be sterilized, followed by application of a vacuum to the sterilization chamber to remove the water and hydrogen peroxide from the article. This method is suitable for surface sterilization, but not for sterilization of diffusion-restricted areas such as long narrow lumens because it depends on the diffusion of hydrogen peroxide vapor into the lumen to effect sterilization. [0005]
  • U.S. Pat. No. 4,943,414 discloses a process in which a vessel containing a small amount of a vaporizable liquid sterilant solution is attached to a lumen, and the sterilant vaporizes and flows directly into the lumen of the article as the pressure is reduced during the sterilization cycle. This system has the advantage that the water and hydrogen peroxide vapor are pulled through the lumen by the existing pressure differential, increasing the sterilization rate for lumens, but has the disadvantage that the vessel needs to be attached to each lumen to be sterilized. In addition, water is vaporized faster and precedes the hydrogen peroxide vapor into the lumen. [0006]
  • In U.S. Pat. No. 5,492,672, there is disclosed a process for sterilizing narrow lumens. This process uses a multicomponent sterilant vapor and requires successive alternating periods of flow of sterilant vapor and discontinuance of such flow. A complex apparatus is used to accomplish the method. Because flow through of vapor is used, closed end lumens are not readily sterilized in the process. [0007]
  • U.S. Pat. No. 4,744,951 to Cummings attempts to address this problem by providing a separate prechamber connected to the sterilization chamber. Hydrogen peroxide is first admitted to the prechamber where it is concentrated in a distillation procedure employing the differing vapor pressures of hydrogen peroxide and water. Water's higher vapor pressure allows one to select a vaporization pressure which selectively vaporizes water from a hydrogen peroxide solution, thus concentrating the solution. Cummings pumps air out of the prechamber and lowers its pressure to a level at which the the water preferentially vaporizes from the hydrogen peroxide solution. The pump which is evacuating the prechamber draws out the water vapor thus released from solution to concentrate the remaining solution. To prevent the water vapor from traveling into the narrow spaces such as endoscope lumens, Cummings carries out the concentration process in the prechamber. This adds complexity be requiring additional chambers, pumps and valves. [0008]
  • Those of skill in the art, both in Cummings day, and now, would not think to employ such a concentration process in the same chamber as the sterilization occurs due to the problem of water vapor rushing to occlude the narrow lumens. In fact, the theory predicts that such a process would sterilize lumens less well than by simply vaporizing all of the hydrogen peroxide solution at once, because the slow vaporization would more efficiently block the lumen with water vapor. However, the present inventors have suprisingly found that concentrating the hydrogen peroxide vapor within the sterilization chamber greatly increases the ability to sterilize long narrow lumens over the convential process of essentially vaporizing all of the hydrogen peroxide at once. [0009]
  • SUMMARY OF THE INVENTION
    BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1 is a schematic diagram of a chamber and accessories suitable for use in the hydrogen peroxide sterilization process of the invention. [0010]
  • FIG. 2 is a schematic diagram of a chamber, pump and throttle valve for use in the hydrogen peroxide sterilization process of the invention. [0011]
  • FIG. 3 is a schematic diagram of a system with one pump and two valves, one valve having a larger pump vacuum line for quicker pumpdown and one having a smaller vacuum line for slower pumpdown. [0012]
  • FIG. 4 is a schematic diagram of a single valve sterilization system having two pumps, one for slower pumpdown and one for quicker pumpdown. [0013]
  • FIG. 5 is a schematic diagram of a system with two pumps and two valves, one pump for slower pumpdown and one for quicker pumpdown. [0014]
  • FIG. 6 is a schematic diagram of a system with a vaporizer. [0015]
  • FIG. 7 is a schematic diagram of a system with an alternative vaporizer. [0016]
  • FIG. 8 is a schematic diagram of a system with a further alternative vaporizer.[0017]
  • DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
  • Sterilizing the inside of lumened devices has always posed a challenge to sterilization systems. Copending U.S. application No. 08/628,965, the entire contents of which are hereby incorporated by reference, discloses a method of hydrogen peroxide vapor sterilization of diffusion-restricted environments, such as long narrow lumens, at pressures less than the vapor pressure of hydrogen peroxide by pretreating the article to be sterilized with a dilute solution of hydrogen peroxide prior to exposure to a vacuum. U.S. Pat. No. 5,851,485, incorporated herein by reference, controls the pumpdown rate. [0018]
  • An apparatus useful in the process of the present invention is shown schematically in FIGS. 1 and 2 and comprises a [0019] chamber 2, a throttle valve 4 and a pump 6. In FIG. 2, the chamber 2 is attached to the pump 6 by the throttle valve 4. The valve 4 can be controlled either automatically or manually to maintain the pressure. In the automatic mode of operation, the throttle valve 4 opens based on the pressure in the chamber via a pressure transducer and valve controller. Such valves are commercially available from, for example, MKS (Andover, Md.).
  • Hydrogen peroxide can be introduced into the system in any fashion. In one emobdiment, a dilute, aqueous solution of hydrogen peroxide is placed in [0020] wells 8 as shown in FIG. 1. The aqueous solution of hydrogen peroxide can also be placed within the lumen of long narrow objects to be sterilized. As the pressure in the sterilization chamber 2 is reduced, the hydrogen peroxide vaporizes and contacts the surface to be sterilized (i.e., colonoscope 10 in FIG. 1) which is placed on metal grid 12 which rests on tray 14. In a preferred embodiment, the tray can be configured with a plurality of wells designed to retain a known volume of liquid sterilant. In one embodiment, the volume of sterilization chamber 2 is about 18.5 liters and its dimensions are about 22″ (55.9 cm)×4.25″ (10.8 cm)×12″ (30.5 cm).
  • FIG. 3 illustrates a parallel two-valve arrangement for use in the sterilization process of the invention. In this embodiment, the [0021] chamber 2 is in fluid communication with the pump 6 via valves 16 and 18. Valve 16 mediates the initial rapid evacuation, the first step of a two step evacuation process. Valve 18 mediates slow evacuation, the second step of the process, which ensures maximal contact of the article to be sterilized with the vaporized aqueous hydrogen peroxide. The pumpdown rate can be controlled by the pumping speed and/or the percent opening of the valve. Either valve can be used to maintain the pressure. In practice, controlling the process so that all of the water evaporates before any of the hydrogen peroxide evaporates is very difficult, yet the preferential evaporation and elimination of water vapor from the system effectively concentrates the hydrogen peroxide therein without the attendant complexity of shipping and handling concentrated hydrogen peroxide solutions prior to vaporization.
  • As the water evaporates from solution its voume greatly increases thus raising the pressure in the system and requiring additional pumping to extract the water vapor to maintain the pressure between the two vapor pressures. Also, the vapor pressures change with changing conditions within the chamber. [0022]
  • FIG. 4 illustrates a sterilization apparatus having two [0023] pumps 20 and 22, and one valve 4. Pump 20 allows quicker pumpdown of the chamber 2, while pump 22 allows slower pumpdown. FIG. 5 illustrates an alternate configuration having two valves 24 and 26 in fluid communication with the pumps 20 and 22, respectively.
  • Regardless of which configuration is used, hydrogen peroxide can be introduced into the chamber as a liquid. In one preferred embodiment, hydrogen peroxide is introduced as a vapor and the chamber parameters are changed so that the vapor condenses as a liquid on the surface of interior of an article to be sterilized. Such changes include increasing the pressure. [0024]
  • The aqueous solutions of hydrogen peroxide can be relatively dilute, e.g. as low as 1-6% peroxide by weight, since sterilization is not achieved through contact with the hydrogen peroxide solution, but rather is achieved at low temperatures (preferably 15°-80° C., more preferably 20°-60° C., still more preferably 40°-55° C.) and in short periods of time (preferably less than one hour, and more preferably less than one-half hour) upon exposure to hydrogen peroxide under vacuum. The method of the present invention is particularly effective with articles having inaccessible or hard-to-reach places. Such articles include long, narrow lumens, hinges and other articles having spaces where diffusion of vapors is restricted. Although hydrogen peroxide is used in the examples described herein, the use of other liquid sterilants which have vapor pressures lower than the vapor pressure of the solvent in which they are provided are also contemplated. Such sterilants include, for example, aqueous peracetic acid solution and aqueous glutaraldehyde solution. [0025]
  • Preferably, the article to be sterilized is contacted with sterilant prior to the vaporization step to localize at least some of the vaporization in the diffusion restricted areas. Such contacting can be accomplished either directly or indirectly. Direct contacting includes methods such as static soaking, flow through, aerosol spray, condensation of a vapor. Any other methods involving physically contacting the articles to be sterilized with sterilant would be considered direct contacting. Indirect contacting includes those methods in which sterilant is introduced into the chamber, but not directly on or in the articles to be sterilized. [0026]
  • At the end of the process, deep vacuum can be used to remove residual sterilant. A plasma can also be used to both enhance sterilization efficacy and to remove residual sterilant. [0027]
  • The pumps shown schematically in the figures can be any commercially available pump. Two preferred pumps are from Leybold Vacuum Products, Inc. (Export, Pa.) (Model D16A, pump rate=400 liters/min) and KNF Neuberger, Inc. (Trenton, N.J., Model N740, pump rate=45 liters/min). The Leybold pump can reach a pressure of less than 0.1 torr and the KNF pump can reach a pressure of less than 10 torr. [0028]
  • For certain substrates being sterilized, such as nylon or polyurethane, excess hydrogen peroxide in the system may leave a residual which is difficult to remove. In order to avoid an excess residual, the vapor concentration of hydrogen peroxide is preferably kept below 30 mg/l, more preferably less than 20 mg/l, and more preferably still less than 15 mg/l. If higher vapor concentrations of hydrogen peroxide are desired, excess residual can be removed using a gas plasma. When using substrates such as stainless steel, polyethylene or polypropylene, which do not retain a residual, there is no reason to limit to the amount of peroxide which can be present in the vapor phase in the system during sterilization. [0029]
  • To further reduce water within the system, the [0030] chamber 2 may be dried prior to the introduction of hydrogen peroxide. Many means may be employed to drive water out of the chamber. Primarily, this is accomplished by vaporizing the water and pumping it out of the chamber. The vaporization can be accomplished with heat, plasma induction, vacuum or the like, either alone or in combination. Merely drawing a vacuum prior to introducing the hydrogen peroxide accomplishes a benficial drying of the chamber 2. If the chamber 2 is heated during this process and if a high energy electromagnetic field is applied to urge the water into the plasma stage the drying is enhanced. U.S. Pat. No. 5,656,238 issued on Aug. 12, 1997 to Spencer at al. and incorporated herein by reference teaches such techniques in more detail.
  • Vaporization of the hydrogen peroxide can be achieved using well known methods as described above; FIGS. [0031] 6 to 8 show several new preferred methods. In FIG. 6, a chamber 30 is evacuated by a pump 32 separated from the chamber 30 by a throttle valve 34. A vaporizer 36 comprises a housing 38 in fluid communication with the chamber 30 and into which extends a liquid feeding nozzle 40 from outside of the chamber 32. A cup 42 within the housing 38 receives hydrogen peroxide from the nozzle 40. The hydrogen peroxide can be vaporized as it exits the nozzle 40, or more preferably in a controlled fashion from the cup 42 by controlling the temperature of the cup 42 and the pressure in the chamber 30. Temperature control of the cup 42 can be as simple as thermally isolating it from the chamber 30, or a more active control system can be employed such a cooling coil or the like to maintain the cup 42 at a desired low temperature. Preferably, the entire vaporizer 36 is thermally isolated from the chamber 30 or temperature controlled in some fashion. Lower temperatures of vaporization enhance the preferential vaporization of water by exploiting the larger difference between the vapor pressures of water and hydrogen peroxide at lower temperatures. Creating a diffusion restriction 44 between the vaporizer 36 and chamber 30 enhances the preferential extraction of water vapor from the chamber as water vapor will more easily traverse the diffusion restriction and be pumped out of the chamber during the vaporization process. The diffusion restriction 44 may be simply reducing the clearance between the cup 42 and housing 38 through with the vapor must travel to reach the chamber 30.
  • FIG. 7 shows a [0032] similar chamber 50, pump 52 and valve 54 with modified vaporizer 56. The vaporizer 56 comprises a chamber 58 separated from the chamber 50 by a diffusion restriction 60, such as a permeable membrane. Liquid hydrogen peroxide solution enters the chamber 58 through a valve 62. FIG. 8 illustrates a similar arrangement with a chamber 70, pump 72, valve 74, and vaporizer 76 with a chamber 78 and valved hydrogen peroxide solution inlet 80. Restriction of the diffusion between the vaporizer chamber 78 and main chamber 70 is variable. During initial vaporization when primarily water is vaporizing the vapors pass through a tight diffusion restriction 82. After the concentration of the hydrogen peroxide solution reaches a given level a valve 84 may be opened to speed the vaporization and diffusion of the concentrated hydrogen peroxide solution.
  • Preferably, the temperature in the chamber is no less than 5° C. nor more than 150° C., with the range of 50 to 65° C. being preferred, and the pressure should be no less than 0.01 torr, nor typically greater than atmosphere during the process, with the lowest vacuum being typically 0.4 torr and the diffusion pressure preferably being between 2 and 10 torr, although other conditions within the spirit of the invention will be apparent to those of skill in the art. During the concentration stage, the pressure should not fall below 0.5 torr. Shorter overall cycles are preferred for convenience, with 5 minutes being a desirable goal, but longer times upwards of 6 hours or more may be warranted in some circumstances. [0033]
  • Tables 1 and 2 illustrate the effectiveness of the present invention. The experiments were run on a chamber of 73 liters at 45° C. with 1780 mg of hydrogen peroxide 59% solution. The diffuser is separated from the chamber by 12 2 mm diameter holes to effect diffusion restriction. [0034]
    TABLE 1
    Test Conditions
    Normal
    Process New Process
    Step Test A Test B Test C Test D Test E
    1 Open valve Open valve Open valve Open valve Open valve
    2 Vacuum to Inject H2O2 at 1 Vacuum to 30 torr Vacuum to 0.3 Vacuum to 0.3
    0.3 torr atm torr torr
    3 Close valve vaporization & Inject H2O2 at 30 Inject H2O2 at Close valve
    diffusion torr 0.3 torr
    4 Inject H2O2 at Vacuum to about Vaporization & Vaporization & Inject H2O2 at
    0.3 torr 2 torr diffusion diffusion 0.3 torr
    5 Vaporization Close valve Vacuum to about 2 Vacuum to Vaporization &
    & diffusion torr about 2 torr diffusion
    6 Vent to 1 atm Vaporization & Close valve Close valve Open valve
    diffusion
    7 Vent to 1 atm Vaporization & Vaporization & Vacuum to
    diffusion diffusion about 2 torr
    8 Vent to 1 atm Vent to 1 atm Close valve
    Vaporization &
    diffusion
    9 Vent to 1 atm
  • [0035]
    TABLE 2
    Sterility test results (positives/samples)
    Normal Process New Process
    Lumen size Test A Test B Test C Test D Test E
    1 × 400 mm 2/2 0/2 0/2 0/2 0/2
    1 × 350 mm 2/2 0/2 0/2 0/2 0/2
    1 × 300 mm 2/2 0/2 0/2 0/2 0/2
    1 × 250 mm 2/2 0/2 0/2 0/2 0/2
  • Monitoring of the temperature, pressure and hydrogen peroxide conditions within the chamber [0036] 30 (FIG. 6) allows the process to be controlled more precisely. Preferably, an automated control system, preferably employing a computer processer, recieves inputs of the temperature, pressure and perhaps also the hydrogen peroxide concentration and calculates the optimal pressure at which to maintain the chamber to remove the water from the hydrogen peroxide solution and from the chamber 30. It can also determine when the solution is sufficiently concentrated. For instance, it may be desired to only concentrate the solution to a certain degree so as to minimize the loss of hydrogen peroxide from the chamber, thereby minimizing hydrogen peroxide emissions from the chamber. While preferentially vaporizing the water from the solution, some hydrogen peroxide will also vaporize. Accordingly, one may wish to balance the efficient use of the quantity of hydrogen peroxide within the solution against the goal of eliminating all water from the solution and the chamber. By monitoring the ratio of water and peroxide the vapor phase, the valve 34 can be controlled to remove the vapor until the desired ratio is achieved. The ratio can be determined using a hydrogen peroxide monitor and a moisture monitor, or by using a hydrogen peroxide monitor and a pressure sensor and then calculating the water using the PVRT equation and making the assumption that water and peroxide are essentially the only gases within the chamber 34.
  • It is known that certain spectra of light passing through the chamber can be measured to determine the hydrogen peroxide concentration. One particular method is disclosed in co-pending U.S. application No. 08/970,925 filed Nov. 14, 1997, incorporated herein by reference. [0037]
  • Table 3 illustrates the effects of the ratio of hydrogen peroxide vapor to water vapor in the [0038] chamber 30 on the ability to sterilize long narrow lumens or other diffusion restricted environments. Water vapor was first introduced into the system and then essentially pure hydrogen peroxide vapor was introduced by liberation from a solid form. The lower concentrations of water show no failures, whereas with the higher ratio in the last column the efficacy decreased and in one test 3 out of 3 samples failed. Table 4 shows similar results by comparing a sterilization process in which the concentration of hydrogen peroxide is not increased according to the present invention with a process in which it is increased. Table 5 shows the degree of concentration achieved according to the present invention. By monitoring the concentration (i.e. the ratio of hydrogen peroxide to water) during the sterilization cycle it should be possible to achieve the long sought goal of parametric release. One could be assured that if the proper concentration was maintained for a sufficient period of time that a particular load of instruments placed within the chamber 30 and sterilized according to the present invention then the process would be sufficiently predictable so as to allow the load to be released for use without further checking with a biological indicator. Typically, such processes always employ a biological indicator in the load, such as with a test load of microorganisms, which is then checked to ensure that sufficient sterilization has been achieved to kill all of the test microorganisms. With parametric release the time consuming process of biological indicators can be skipped.
    TABLE 3
    Effect of water to peroxide ratio on efficacy
    Efficacy with Bacllius subtilis var. niger on SS blade
    in 3 mm × 500 mm
    Figure US20020119075A1-20020829-P00801
    LTU in 173 L chamber
    Sterility results (positives/samples)
    Diffusion time 0.653 mg/L H2O 3.266 mg/L H2O 6.532 mg/L H2O
    (minutes) 6 mg/L H2O2 6 mg/L H2O2 6 mg/L H2O2
     5 0/3 0/3 3/3
    10 0/3 0/3 2/3
    15 0/3 0/3 0/3
    30 0/3 0/3 0/3
  • [0039]
    TABLE 4
    (A) Effect of water to peroxide ratio on efficacy
    59% solution
    Sterility results positives/samples
    Without
    concentrating
    process With concentrating process
    Lumen Dimension 8.43 mg/L H2O 1.49 mg/L H2O
    (Diameter) × (length) 12 mg/L H2O2 7.3 mg/L H2O2
    1 × 400 mm 2/2 0/2
    1 × 350 mm 2/2 0/2
    1 × 300 mm 2/2 0/2
    1 × 250 mm 2/2 0/2
  • [0040]
    TABLE 5
    Concentrating the 59% peroxide solution
    Ratio of peroxide to water
    After all
    Before Right after peroxide
    concentrating concentrating vaporize
    Vaporization in vaporizer 1.4:1   19:1 none
    Vaporization in chamber <1.4:1 0.85:1 4.9:1
  • The process may be further enhanced by admitting sufficient hydrogen peroxide into the system so as to force some of the vaporized solution to condense upon the instruments being sterilized within the system. As described above, the solution can be vaporized by admitting it into the system at any pressure above the vapor pressures of water and hydrogen peroxide in the solution and then vaporized by reducing the pressure, or by admitting the solution at a pressure substantially below these vapor pressures whereupon it will start to vaporize thus releasing gas and increasing the pressure. In the second scenario if the pressure is then further reduced by pumping the concentration of the hydrogen peroxide in the system can be increased. This is especially true if the pressure rises to a level at least above the vapor pressure of hydrogen peroxide thereby limiting further vaporization of hydrogen peroxide from solution and perhaps encouraging some of the hydrogen peroxide to condense upon objects such as instruments within the system. Some of the water vapor would likely also condense in such event. By controlling the pressure excess water vapor would be exhausted from the system and then the condensed solution would re-vaporize. To the extent that such solution had condensed within diffusion restricted areas the re-vaporization therein would further increase the concentration in the those areas to enhance the sterilization efficacy therein. The quantity of solution admitted will primarily determine the pressure rise to initiate such condensaation. The process is described in more detail in our co-pending application entitled “Sterilization of Diffusion-Restricted Area by Re-Vaporizing the Condensed Vapor” filed contemporaneously herewith. [0041]
  • A typical cycle might comprise placing a load of instruments (not shown) within a CSR wrapped tray within the [0042] chamber 30 and then drawing a vacuum on the chamber 30 with the pump 32 down to below 1 torr or about 0.4 torr. An electromagnetic field applied to the chamber 30 at such time tends to drive any remaining water into the vapor or plasma stage so that it can be removed by the pump 32. The pump 32 can be cycled or merely run continuously with the valve 34 controlling the vacuum process. Fresh dry air may be admitted to the chamber 30 including raising of the pressure back to atmosphere. Preferably the hydrogen peroxide solution, preferably a 59% hydrogen peroxide solution, is admitted to the vaporizer 36 at atmospheric pressure and then the pump 32 exhausts the chamber 30 to a level at which the solution begins to vaporize. A monitor 100 for hydrogen peroxide vapor and monitor 102 (see FIG. 6) for water vapor in connection with an automated control system 104 can be employed to optimize the pressure conditions to enhance the initial vaporization and exhaust of water vapor. After the solution is sufficiently concentrated the pressure in the chamber 30 can be further lowered to vaporize the remaining solution. The valve 32 is closed to isolate the chamber 30, and the vaporized hydrogen peroxide solution is allowed to diffuse throughout the chamber to contact the instruments. Additional dry air or other gas can be admitted at this time to help push the sterizing vapors into diffusion restricted areas, with the chamber 30 then further exhausted to resume a vacuum in the range of 2 to 10 torr. Additional admissions of air and vacuum can be employed, especially in connection with additional admission and concentration of hydrogen peroxide solutions. After the hydrogen peroxide vapors have diffused throughout the chamber for a sufficient time aan electromagnetic field may be applied to drive the vapor into the plasma stage and effect further steilization. When the field is removed the ions formed from the hydrogen peroxide recombine as water and oxygen, leaving little residual hydrogen peroxide. The chamber can be raised to atmospheric pressure and the load removed.
  • It should be noted that the present invention is not limited to only those embodiments described in the Detailed Description. Any embodiment which retains the spirit of the present invention should be considered to be within its scope. However, the invention is only limited by the scope of the following claims. [0043]

Claims (20)

What is claimed is:
1. A method of furnishing concentrated hydrogen peroxide vapor to an article comprising the steps of:
placing the article into a chamber containing an inner atmosphere;
placing a solution comprising hydrogen peroxide and water into fluid communication with the chamber, said solution having a ratio of hydrogen peroxide to water;
vaporizing the solution in the inner atmosphere to form water vapor and hydrogen peroxide vapor;
selectively drawing water vapor from the chamber to increase a ratio of hydrogen peroxide to water in the chamber; and
contacting the article with the hydrogen peroxide vapor.
2. A method according to claim 1 wherein the ratio of hydrogen peroxide vapor to water vapor after the step of selectively drawing water vapor from the chamber exceeds the ratio of hydrogen peroxide to water in said solution.
3. A method according to claim 1 wherein the ratio of hydrogen peroxide to water, by weight, after the step of selectively drawing water vapor from the chamber exceeds 3 to 1.
4. A method according to claim 3 wherein the ratio of hydrogen peroxide to water in said solution, by weight, is less than 3 to 1.
5. A method according to claim 3 wherein the ratio of hydrogen peroxide to water in said solution, by weight, is less than 3:2.
6. A method according to claim 3 wherein the ratio of hydrogen peroxide to water, by weight, after the step of selectively drawing water vapor from the chamber exceeds 4 to 1.
7. A method according to claim 1 wherein the step of selectively drawing water vapor from the chamber comprises placing said solution within a diffusion restricted environment in fluid communication with the chamber during the step of vaporizing the solution.
8. A method according to claim 7 wherein the diffusion restricted environment is more diffusion restricted during the step of selectively drawing water vapor from the chamber than during a portion of the step of vaporizing the solution during which the hydrogen peroxide is vaporizing at a faster rate than the water.
9. A method according to claim 7 wherein the water vapor is drawn from the chamber through one or more exhaust ports and wherein the one or more exhaust ports are physically remote from the diffusion restriction.
10. A method according to claim 1 wherein the step of selectively drawing water vapor from the chamber comprises the steps of controlling the temperature and pressure of the solution during the step of vaporizing the solution to enhance vaporization of the water from solution versus vaporization of hydrogen peroxide and extracting at least a portion of the water vapor from the chamber.
11. A method according to claim 1 wherein the step of selectively drawing water vapor from the chamber comprises the steps of maintaining the solution at a pressure below the vapor pressure of the water in the solution and above the vapor pressure of the hydrogen peroxide in the solution.
12. A method according to claim 1 wherein the solution is vaporized by pumping a portion of the atmosphere out of the chamber to lower the pressure of the chamber at a rate selected to control removal of the water and hydrogen peroxide from the solution so as to concentrate the hydrogen peroxide remaining in the chamber.
13. A method according to claim 1 wherein the temperature of the solution during the vaporizing step is held below the temperature of the atmosphere in the chamber whereby to increase the vapor pressure of the water in the solution relative to the hydrogen peroxide in the solution whereby to enhance vaporization of the water from the solution in preference to vaporizing the hydrogen peroxide from the solution.
14. A method according to claim 10 wherein the temperature of the atmosphere in the chamber is above room temperature and the temperature of the solution during the vaporizing step is at least 10° C. below the temperature of the atmosphere in the chamber.
15. A method according to claim 13 wherein the solution is vaporized in a vaporizer which is in fluid communication with the chamber and wherein the vaporizer is thermally isolated from the chamber.
16. A method according to claim 1 and further comprising the steps of controlling the temperature and pressure of the solution during a least a first portion of the vaporizing step so as to selectively vaporize water from the solution and concentrate hydrogen peroxide therein to form a concentrated solution and during a second portion of the vaporizing step raising the temperature of the concentrated solution and vaporizing the concentrated solution.
17. A method according to claim 1 and further comprising the steps of controlling the temperature and pressure of the solution during a least a first portion of the vaporizing step so as to selectively vaporize water from the solution and concentrate hydrogen peroxide therein to form a concentrated solution and during a second portion of the vaporizing step not withdrawing atmosphere from the chamber.
18. A method according to claim 1 and further comprising the step of drying the chamber prior to the step of vaporizing the solution.
19. A method according to claim 12 wherein the step of drying the chamber comprises pumping a portion of the atmosphere out of the chamber.
20. A method according to claim 12 wherein the step of drying the chamber comprises applying energy to excite molecules of liquid water within the chamber into the gaseous or plasma state of matter and pumping a portion of the atmosphere out of the chamber.
US09/975,714 1996-04-04 2001-10-11 Apparatus and process for concentrating a liquid sterilant and sterilizing articles therewith Abandoned US20020119075A1 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
US09/975,714 US20020119075A1 (en) 1998-12-30 2001-10-11 Apparatus and process for concentrating a liquid sterilant and sterilizing articles therewith
US10/403,140 US7252800B2 (en) 1998-12-30 2003-03-31 Sterilization system and method and inlet control apparatus therefor
US10/764,861 US20040170527A1 (en) 1996-04-04 2004-01-26 Apparatus and process for concentrating a liquid sterilant and sterilizing articles therewith
US11/093,526 US7670550B2 (en) 1998-12-30 2005-03-30 Rapid sterilization system
US11/414,003 US20070014691A1 (en) 1998-12-30 2006-04-28 Rapid sterilization system

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/223,479 US6325972B1 (en) 1998-12-30 1998-12-30 Apparatus and process for concentrating a liquid sterilant and sterilizing articles therewith
US09/975,714 US20020119075A1 (en) 1998-12-30 2001-10-11 Apparatus and process for concentrating a liquid sterilant and sterilizing articles therewith

Related Parent Applications (2)

Application Number Title Priority Date Filing Date
US09/223,479 Continuation US6325972B1 (en) 1996-04-04 1998-12-30 Apparatus and process for concentrating a liquid sterilant and sterilizing articles therewith
US09/223,479 Continuation-In-Part US6325972B1 (en) 1996-04-04 1998-12-30 Apparatus and process for concentrating a liquid sterilant and sterilizing articles therewith

Related Child Applications (3)

Application Number Title Priority Date Filing Date
US10/403,140 Continuation-In-Part US7252800B2 (en) 1998-12-30 2003-03-31 Sterilization system and method and inlet control apparatus therefor
US10/764,861 Continuation US20040170527A1 (en) 1996-04-04 2004-01-26 Apparatus and process for concentrating a liquid sterilant and sterilizing articles therewith
US11/093,526 Continuation-In-Part US7670550B2 (en) 1998-12-30 2005-03-30 Rapid sterilization system

Publications (1)

Publication Number Publication Date
US20020119075A1 true US20020119075A1 (en) 2002-08-29

Family

ID=22836677

Family Applications (5)

Application Number Title Priority Date Filing Date
US09/223,479 Expired - Lifetime US6325972B1 (en) 1996-04-04 1998-12-30 Apparatus and process for concentrating a liquid sterilant and sterilizing articles therewith
US09/474,285 Expired - Lifetime US6627150B1 (en) 1998-12-30 1999-12-29 Method of sterilizing an article and certifying the article as sterile
US09/474,142 Expired - Lifetime US6656426B1 (en) 1998-12-30 1999-12-29 Process for concentrating a sterilant and sterilizing articles therewith
US09/975,714 Abandoned US20020119075A1 (en) 1996-04-04 2001-10-11 Apparatus and process for concentrating a liquid sterilant and sterilizing articles therewith
US10/764,861 Abandoned US20040170527A1 (en) 1996-04-04 2004-01-26 Apparatus and process for concentrating a liquid sterilant and sterilizing articles therewith

Family Applications Before (3)

Application Number Title Priority Date Filing Date
US09/223,479 Expired - Lifetime US6325972B1 (en) 1996-04-04 1998-12-30 Apparatus and process for concentrating a liquid sterilant and sterilizing articles therewith
US09/474,285 Expired - Lifetime US6627150B1 (en) 1998-12-30 1999-12-29 Method of sterilizing an article and certifying the article as sterile
US09/474,142 Expired - Lifetime US6656426B1 (en) 1998-12-30 1999-12-29 Process for concentrating a sterilant and sterilizing articles therewith

Family Applications After (1)

Application Number Title Priority Date Filing Date
US10/764,861 Abandoned US20040170527A1 (en) 1996-04-04 2004-01-26 Apparatus and process for concentrating a liquid sterilant and sterilizing articles therewith

Country Status (8)

Country Link
US (5) US6325972B1 (en)
EP (2) EP1146915B2 (en)
JP (2) JP2002540815A (en)
AU (2) AU755983C (en)
CA (2) CA2357838C (en)
DE (2) DE69933137T2 (en)
ES (2) ES2273518T3 (en)
WO (2) WO2000038746A1 (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060078459A1 (en) * 2004-10-12 2006-04-13 Kohler James P Sterilization system and method and orifice inlet control apparatus therefor
US20070172383A1 (en) * 2002-06-28 2007-07-26 Williams Harold R Sterilizer with restrictor
US20080187465A1 (en) * 2007-02-05 2008-08-07 Steris Inc. Instrument container having multiple chambers with flow pathways therebetween
US20080199355A1 (en) * 2005-08-04 2008-08-21 Saban Ventures Pty Limited Membrane Concentrator
US9050385B2 (en) 2007-02-02 2015-06-09 Saban Ventures Pty Limited Methods of disinfection or sterilization
US10905786B2 (en) 2017-03-27 2021-02-02 Regeneron Pharmaceuticals, Inc. Sterilisation method

Families Citing this family (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6325972B1 (en) * 1998-12-30 2001-12-04 Ethicon, Inc. Apparatus and process for concentrating a liquid sterilant and sterilizing articles therewith
US6852279B2 (en) * 2002-06-28 2005-02-08 Ethicon, Inc. Sterilization with temperature-controlled diffusion path
US7670550B2 (en) * 1998-12-30 2010-03-02 Ethicon, Inc. Rapid sterilization system
US7252800B2 (en) * 1998-12-30 2007-08-07 Ethicon, Inc. Sterilization system and method and inlet control apparatus therefor
US7588720B2 (en) * 1999-04-30 2009-09-15 Tso3, Inc. Method and apparatus for ozone sterilization
US7128872B2 (en) * 1999-04-30 2006-10-31 Tso3 Inc. Method and apparatus for ozone sterilization
GB2354443A (en) 1999-09-21 2001-03-28 Microflow Ltd Vapour phase sterilisation
US7094322B1 (en) 1999-12-15 2006-08-22 Plasmasol Corporation Wall Township Use of self-sustained atmospheric pressure plasma for the scattering and absorption of electromagnetic radiation
KR20030031879A (en) * 1999-12-15 2003-04-23 스티븐스 인스티튜트 오프 테크놀로지 Segmented electrode capillary discharge, non-thermal plasma apparatus and process for promoting chemical reactions
US6923890B2 (en) * 1999-12-15 2005-08-02 Plasmasol Corporation Chemical processing using non-thermal discharge plasma
US6955794B2 (en) 1999-12-15 2005-10-18 Plasmasol Corporation Slot discharge non-thermal plasma apparatus and process for promoting chemical reaction
US7192553B2 (en) 1999-12-15 2007-03-20 Plasmasol Corporation In situ sterilization and decontamination system using a non-thermal plasma discharge
US7029636B2 (en) 1999-12-15 2006-04-18 Plasmasol Corporation Electrode discharge, non-thermal plasma device (reactor) for the pre-treatment of combustion air
US6528016B1 (en) * 2000-06-27 2003-03-04 Ethicon, Inc. Method for rapidly determining the acceptability of loads to be sterilized
DE10103706A1 (en) * 2001-01-26 2002-08-14 Aventis Behring Gmbh Use of a hydrogen peroxide plasma sterilization process for the gentle sterilization of temperature-sensitive products
DE10114758B4 (en) * 2001-03-20 2013-01-31 Ptm Packaging Tools Machinery Pte. Ltd. Method for sterilizing containers
WO2003005397A2 (en) 2001-07-02 2003-01-16 Plasmasol Corporation A novel electrode for use with atmospheric pressure plasma emitter apparatus and method for using the same
EP1451850A2 (en) * 2001-11-02 2004-09-01 Plasmasol Corporation Non-thermal plasma slit discharge apparatus
US7091042B2 (en) * 2001-11-02 2006-08-15 Ethicon, Inc. Variable resistance sterilization process challenge device and method
US20040050684A1 (en) * 2001-11-02 2004-03-18 Plasmasol Corporation System and method for injection of an organic based reagent into weakly ionized gas to generate chemically active species
US20030124026A1 (en) * 2001-11-05 2003-07-03 Hal Williams Apparatus and process for concentrating a sterilant and sterilizing articles therewith
EP1852132B1 (en) 2002-03-28 2012-10-03 Bioquell UK Limited Method and apparatus for decontaminating enclosed spaces
US7807100B2 (en) * 2002-06-28 2010-10-05 Ethicon, Inc. Sterilization system and method with temperature-controlled condensing surface
KR100414360B1 (en) * 2002-11-08 2004-01-16 주식회사 휴먼메디텍 Sterilizer and Sterilization methode with Plasma Treatment Apparatus
US7402678B2 (en) * 2004-12-17 2008-07-22 3M Innovative Properties Company Multifunctional amine capture agents
EP1715898A4 (en) * 2004-01-22 2007-05-30 Plasmasol Corp Modular sterilization system
CA2553804A1 (en) * 2004-01-22 2005-08-04 Plasmasol Corporation Capillary-in-ring electrode gas discharge generator for producing a weakly ionized gas and method for using the same
US7452504B2 (en) * 2004-05-28 2008-11-18 Ethicon, Inc. Sterilization/disinfection cycle control
DE112005002948T5 (en) * 2004-11-26 2008-01-24 Human Meditek Co., Ltd. Hydrogen peroxide steam sterilizer and sterilization process for use thereof
US7642067B2 (en) * 2005-06-30 2010-01-05 Ethicon, Inc. Device and method for rapidly determining the effectiveness of sterilization or disinfection processes
US7429353B2 (en) * 2005-07-21 2008-09-30 American Sterilizer Company Method and apparatus for injecting a metered quantity of a liquid into a chamber
AU2012244325B2 (en) * 2005-08-04 2015-02-05 Saban Ventures Pty Limited Improved aerosol
US20070048176A1 (en) * 2005-08-31 2007-03-01 Plasmasol Corporation Sterilizing and recharging apparatus for batteries, battery packs and battery powered devices
US20070231202A1 (en) * 2006-03-31 2007-10-04 Roberts Charles G method and system for prion inactivation
ATE489973T1 (en) * 2006-05-01 2010-12-15 American Sterilizer Co HYDROGEN PEROXIDE ATOMIZER
US20090074881A1 (en) * 2006-05-02 2009-03-19 Bioneutral Laboratories Corporation Usa Antimicrobial cidality formulations with residual efficacy, uses thereof, and the preparation thereof
US9034390B2 (en) * 2006-05-02 2015-05-19 Bioneutral Laboratories Corporation Anti-microbial composition and method for making and using same
GB0710331D0 (en) 2007-05-30 2007-07-11 Bioquell Uk Ltd Improved in or relating to methods of decontaminating enclosed spaces
JP5220853B2 (en) * 2007-07-10 2013-06-26 エルデル、ダ、コスタ、ゴンカルベス Method and apparatus for hydrogen peroxide sterilization
US20090110708A1 (en) * 2007-10-30 2009-04-30 Platt Robert C Animate tissue antisepsis
CA2729603C (en) * 2008-06-30 2019-04-30 Saban Ventures Pty Limited Aerosol sensor
US8889081B2 (en) 2009-10-15 2014-11-18 Medivators Inc. Room fogging disinfection system
AU2010325926B2 (en) 2009-12-03 2014-01-09 Minntech Corporation Container and system for decontaminating a medical device with a fog
US8840836B2 (en) 2011-04-27 2014-09-23 Sterilucent, Inc. Sterilization method with compression and expansion
US9017607B2 (en) 2011-05-27 2015-04-28 Medivators Inc. Decontamination system including environmental control using a decontaminating substance
US9522205B2 (en) * 2012-08-02 2016-12-20 Getinge Stericool Mekical Altetler San. Ve Tic. A.S. Multi mode low temperature plasma sterilizer
US10709803B2 (en) 2013-09-06 2020-07-14 Ts03 Inc. Sterilization apparatus and adaptive control thereof
CN105658246B (en) 2013-09-06 2020-08-18 大诚臭氧公司 Sterilization method and apparatus and adaptive control thereof
US10596287B2 (en) 2016-03-02 2020-03-24 Asp Global Manufacturing Gmbh Apparatus and method to link medical device sterilization equipment
US10443083B2 (en) 2016-03-02 2019-10-15 Asp Global Manufacturing Gmbh Apparatus and method for analyzing biological indicators
US10668180B2 (en) 2016-03-02 2020-06-02 Asp Global Manufacturing Gmbh Apparatus and method for sterilizing medical devices
US10561753B2 (en) 2016-03-02 2020-02-18 Asp Global Manufacturing Gmbh Method of sterilizing medical devices, analyzing biological indicators, and linking medical device sterilization equipment
US10314929B2 (en) 2016-06-30 2019-06-11 Ethicon, Inc. Apparatus and method for sterilizing endoscope
US11696967B2 (en) 2016-06-30 2023-07-11 Asp Global Manufacturing Gmbh Apparatus and method for sterilizing endoscope
US10632220B2 (en) 2016-09-15 2020-04-28 Asp Global Manufacturing Gmbh Biological indicator with variable resistance
US10500297B2 (en) 2016-11-21 2019-12-10 Asp Global Manufacturing Gmbh Apparatus and method for detecting improper positioning of removable component of sterilizing system
US20180147309A1 (en) 2016-11-29 2018-05-31 Ethicon, Inc. Sterilization system with independent vacuum chambers
US20180237821A1 (en) 2017-02-23 2018-08-23 Ethicon, Inc. Apparatus and method to read biological indicator
US10814027B2 (en) 2017-12-07 2020-10-27 Asp Global Manufacturing Gmbh Sterilization-assistance device
US10967084B2 (en) 2017-12-15 2021-04-06 Asp Global Manufacturing Gmbh Flow restrictor
US20200038101A1 (en) 2018-08-03 2020-02-06 Biosense Webster (Israel) Ltd. Unipolar reference electrode for electrophysiology mapping catheter
WO2020202920A1 (en) * 2019-04-04 2020-10-08 ニッタ株式会社 Decontamination device and system
US11744480B2 (en) 2019-06-25 2023-09-05 Biosense Webster (Israel) Ltd. Catheter deflection system with deflection load limiter
US11540878B2 (en) 2019-07-17 2023-01-03 Biosense Webster (Israel) Ltd. Blooming leaflet catheter with high density electrode array
JP2023523542A (en) 2020-04-08 2023-06-06 エイエスピー・グローバル・マニュファクチャリング・ゲーエムベーハー How to sterilize an endoscope

Family Cites Families (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4169123A (en) 1975-12-11 1979-09-25 Moore-Perk Corporation Hydrogen peroxide vapor sterilization method
US4102055A (en) * 1977-03-28 1978-07-25 Borg-Warner Corporation Sensitive inclinometer
US4169124A (en) 1977-09-26 1979-09-25 Moore-Perk Corporation Cold gas sterilization process
US4230669A (en) * 1978-07-17 1980-10-28 Pullman Incorporated Radial ammonia converter
US4512951A (en) * 1980-12-30 1985-04-23 American Sterilizer Company Hydrogen peroxide liquid film sterilization method
US4337223A (en) * 1981-02-13 1982-06-29 Ben Venue Laboratories, Inc. Sterilizing apparatus incorporating recirculation of chamber atmosphere
US4410492A (en) * 1981-02-13 1983-10-18 Ben Venue Laboratories, Inc. Sterilizing method incorporating recirculation of chamber atmosphere
GB8427999D0 (en) 1983-11-07 1984-12-12 American Sterilizer Co Vaporization method
JPS60188917A (en) * 1984-03-07 1985-09-26 Asahi Optical Co Ltd Lens system for photographing short distance
US4642165A (en) * 1984-12-21 1987-02-10 American Sterilizer Company Method of vaporizing multicomponent liquids
US4643876A (en) 1985-06-21 1987-02-17 Surgikos, Inc. Hydrogen peroxide plasma sterilization system
US4756882A (en) * 1985-06-21 1988-07-12 Surgikos Inc. Hydrogen peroxide plasma sterilization system
US5552115A (en) * 1986-02-06 1996-09-03 Steris Corporation Microbial decontamination system with components porous to anti-microbial fluids
JPS6311163A (en) * 1986-03-24 1988-01-18 雪印乳業株式会社 Sterilizing method and apparatus
US5302343A (en) * 1987-02-25 1994-04-12 Adir Jacob Process for dry sterilization of medical devices and materials
US5087418A (en) * 1987-02-25 1992-02-11 Adir Jacob Process for dry sterilization of medical devices and materials
US4899519A (en) 1987-05-20 1990-02-13 Surgikos, Inc. Fluid injection system cassette and fluid packaging methods
US4817800A (en) 1987-05-20 1989-04-04 Surgikos, Inc. Fluid injection system cassette and fluid packaging methods
US4909999A (en) * 1987-07-06 1990-03-20 American Sterilizer Company Flow-through vapor phase sterilization system
US5580530A (en) * 1987-07-30 1996-12-03 Johnson & Johnson Medical, Inc. Device for vapor sterilization of articles having lumens
US4943414A (en) 1987-07-30 1990-07-24 Johnson & Johnson Medical, Inc. Method for vapor sterilizaton of articles having lumens
US4956145A (en) 1987-12-30 1990-09-11 American Sterilizer Company Optimum hydrogen peroxide vapor sterilization method
US4952370A (en) 1988-05-06 1990-08-28 American Sterilizer Company Hydrogen peroxide sterilization method
JPH02279160A (en) * 1989-03-08 1990-11-15 Abtox Inc Plasma sterilization method and plasma sterilizer
US5413760A (en) * 1989-03-08 1995-05-09 Abtox, Inc. Plasma sterilizer and method
CN1022542C (en) * 1990-07-26 1993-10-27 北京大学 Perovskite-type rare-earth composite oxides catalyst for combustion
US5244629A (en) * 1990-08-31 1993-09-14 Caputo Ross A Plasma sterilizing process with pulsed antimicrobial agent pretreatment
GB9020559D0 (en) * 1990-09-20 1990-10-31 Keymed Medicals & Ind Equip Cleaning and disinfecting medical instruments
US5310524A (en) * 1992-02-11 1994-05-10 Minntech Corporation Catheter reprocessing and sterilizing system
WO1993017726A1 (en) 1992-03-13 1993-09-16 American Sterilizer Company Sterilization apparatus and method for multicomponent sterilant
WO1993017727A1 (en) * 1992-03-13 1993-09-16 American Sterilizer Company Device and system for sterilizing objects
US5346075A (en) * 1992-04-17 1994-09-13 Johnson & Johnson Medical, Inc. Apparatus and method for holding a medical instrument
US5286448A (en) * 1993-02-04 1994-02-15 American Sterilizer Company Method of decontaminating a chamber that has movable shelves
US6036918A (en) 1993-03-17 2000-03-14 Enviro Medical Systems, Inc. Vapor sterilization
US5558841A (en) * 1993-04-26 1996-09-24 Olympus Optical Co., Ltd. Washing/sterilizing apparatus for an endoscope and method for washing/sterilizing its water supplying system
RU2123971C1 (en) * 1993-04-29 1998-12-27 Саес Геттерс С.П.А. Method and apparatus for removing gas impurities from hydrogen flow
JP3530954B2 (en) * 1994-03-24 2004-05-24 清之 竹迫 Far-infrared sterilizer
US5667753A (en) * 1994-04-28 1997-09-16 Advanced Sterilization Products Vapor sterilization using inorganic hydrogen peroxide complexes
US5674450A (en) * 1994-04-28 1997-10-07 Johnson & Johnson Medical, Inc. Vapor sterilization using a non-aqueous source of hydrogen peroxide
US5882589A (en) * 1994-06-03 1999-03-16 Leon Shipper Sealed endoscope decontamination, disinfection and drying device
US5656238A (en) 1994-10-11 1997-08-12 Johnson & Johnson Medical, Inc. Plasma-enhanced vacuum drying
US5570739A (en) * 1994-12-07 1996-11-05 Foster Wheeler Development Corporation Anti-vibration spacers used in tubular type heat exchangers
US5527608A (en) * 1994-12-27 1996-06-18 Mobil Oil Corporation Oriented multilayer heat sealable packaging film capable of withstanding high altitude effects
US5633424A (en) * 1994-12-29 1997-05-27 Graves; Clinton G. Device and methods for plasma sterilization
US5600142A (en) * 1995-05-26 1997-02-04 Uop Measurement of vaporized hydrogen peroxide
US5711921A (en) * 1996-01-02 1998-01-27 Kew Import/Export Inc. Medical cleaning and sterilizing apparatus
US5788925A (en) 1996-02-16 1998-08-04 Steris Corporation Method for real time monitoring and control of load sterilization and parametric release
US6495100B1 (en) * 1996-04-04 2002-12-17 Ethicon, Inc. Method for sterilizing devices in a container
US6030579A (en) * 1996-04-04 2000-02-29 Johnson & Johnson Medical, Inc. Method of sterilization using pretreatment with hydrogen peroxide
US6325972B1 (en) * 1998-12-30 2001-12-04 Ethicon, Inc. Apparatus and process for concentrating a liquid sterilant and sterilizing articles therewith
US5851485A (en) 1996-12-20 1998-12-22 Johnson & Johnson Medical, Inc. Process for sterilization with liquid sterilant using controlled pumpdown rate
US5804139A (en) * 1996-12-20 1998-09-08 Ethicon, Inc. Two-step sterilization process using liquid sterilant
US5792422A (en) * 1996-12-20 1998-08-11 Ethicon, Inc. Liquid/vapor sterilization container systems
US6528017B2 (en) * 1997-04-04 2003-03-04 Ethicon, Inc. System and method for sterilizing a lumen device
DE19714298A1 (en) * 1997-04-07 1998-10-08 Scican Division Of Lux & Zwing Adapter for a sterilization container in the form of a cassette
US6203756B1 (en) * 1997-12-17 2001-03-20 Johnson & Johnson Medical, Inc. Integrated cleaning sterilization process
US6039922A (en) * 1997-08-15 2000-03-21 Tetra Laval Holdings & Finance, Sa UV radiation and vapor-phase hydrogen peroxide sterilization packaging
AU753047B2 (en) 1997-11-14 2002-10-03 Ethicon Inc. Method for measuring the concentration of hydrogen peroxide vapor
US6013227A (en) * 1997-12-17 2000-01-11 Johnson & Johnson Medical, Inc. Lumen device reprocessor without occlusion
US6015529A (en) * 1997-12-17 2000-01-18 Johnson & Johnson Medical, Inc. Tray/container system for cleaning/sterilization processes
US6010662A (en) * 1998-06-18 2000-01-04 Ethicon, Inc. Two-step sterilization process using liquid sterilant
US6162395A (en) * 1998-08-17 2000-12-19 Enviromedical Systems, Inc. Sterilization of elongate lumens
US6451254B1 (en) * 1998-12-30 2002-09-17 Ethicon, Inc. Sterilization of diffusion-restricted area by revaporizing the condensed vapor
US6852279B2 (en) * 2002-06-28 2005-02-08 Ethicon, Inc. Sterilization with temperature-controlled diffusion path
US6589487B1 (en) * 2000-05-30 2003-07-08 Pao Ly Scent dispensing apparatus
JP4005780B2 (en) * 2001-07-12 2007-11-14 興和株式会社 Digital watermark embedding and detection

Cited By (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070172383A1 (en) * 2002-06-28 2007-07-26 Williams Harold R Sterilizer with restrictor
US7569180B2 (en) 2004-10-12 2009-08-04 Ethicon, Inc. Sterilization system and method and orifice inlet control apparatus therefor
US8658092B2 (en) 2004-10-12 2014-02-25 Ethicon, Inc. Sterilization system and method and orifice inlet control apparatus therefor
US20060078459A1 (en) * 2004-10-12 2006-04-13 Kohler James P Sterilization system and method and orifice inlet control apparatus therefor
US20090324445A1 (en) * 2004-10-12 2009-12-31 Ethicon, Inc. Sterilization system and method and orifice inlet control apparatus therefor
US8444919B2 (en) 2005-08-04 2013-05-21 Saban Ventures Pty Limited Space disinfection
US9192164B2 (en) 2005-08-04 2015-11-24 Saban Ventures Pty Ltd Membrane sterilization
US20080223404A1 (en) * 2005-08-04 2008-09-18 Saban Ventures Pty Limited Space Disinfection
US20080219884A1 (en) * 2005-08-04 2008-09-11 Saban Ventures Pty Limited Aerosol
US9241491B2 (en) 2005-08-04 2016-01-26 Saban Ventures Pty Limited Aerosol
US20080199355A1 (en) * 2005-08-04 2008-08-21 Saban Ventures Pty Limited Membrane Concentrator
US8591807B2 (en) 2005-08-04 2013-11-26 Saban Ventures Pty Limited Membrane sterilization
US8591808B2 (en) * 2005-08-04 2013-11-26 Saban Ventures Pty Limited Aerosol
US8658089B2 (en) 2005-08-04 2014-02-25 Saban Ventures Pty Limited Membrane concentrator
US20080240981A1 (en) * 2005-08-04 2008-10-02 Saban Ventures Pty Limited Membrane Sterilization
US8974737B2 (en) 2005-08-04 2015-03-10 Saban Ventures Pty Limited Space Disinfection
US9138005B2 (en) 2005-08-04 2015-09-22 Saban Ventures Pty Limited Membrane concentrator
US9050385B2 (en) 2007-02-02 2015-06-09 Saban Ventures Pty Limited Methods of disinfection or sterilization
US20080187465A1 (en) * 2007-02-05 2008-08-07 Steris Inc. Instrument container having multiple chambers with flow pathways therebetween
US7744832B2 (en) 2007-02-05 2010-06-29 American Sterilizer Company Instrument container having multiple chambers with flow pathways therebetween
US10905786B2 (en) 2017-03-27 2021-02-02 Regeneron Pharmaceuticals, Inc. Sterilisation method
US10918754B2 (en) 2017-03-27 2021-02-16 Regeneron Pharmaceuticals, Inc. Sterilisation method

Also Published As

Publication number Publication date
DE69931280T3 (en) 2010-01-28
WO2000038745A1 (en) 2000-07-06
AU755983B2 (en) 2003-01-02
ES2263296T5 (en) 2009-12-14
ES2273518T3 (en) 2007-05-01
EP1140220A1 (en) 2001-10-10
AU755860B2 (en) 2003-01-02
DE69931280T2 (en) 2007-05-10
ES2263296T3 (en) 2006-12-01
JP2002540815A (en) 2002-12-03
DE69931280D1 (en) 2006-06-14
EP1146915B1 (en) 2006-05-10
WO2000038746A1 (en) 2000-07-06
US6627150B1 (en) 2003-09-30
EP1140220A4 (en) 2002-08-21
EP1146915B2 (en) 2009-09-02
US6656426B1 (en) 2003-12-02
EP1146915A1 (en) 2001-10-24
AU2715800A (en) 2000-07-31
EP1140220B1 (en) 2006-09-06
AU755983C (en) 2004-07-08
CA2357838A1 (en) 2000-07-06
CA2357838C (en) 2010-06-22
DE69933137D1 (en) 2006-10-19
US20040170527A1 (en) 2004-09-02
US6325972B1 (en) 2001-12-04
DE69933137T2 (en) 2007-08-09
CA2357843A1 (en) 2000-07-06
JP2002533163A (en) 2002-10-08
CA2357843C (en) 2007-04-03
EP1146915A4 (en) 2003-07-02
AU2395500A (en) 2000-07-31

Similar Documents

Publication Publication Date Title
US6325972B1 (en) Apparatus and process for concentrating a liquid sterilant and sterilizing articles therewith
US5851485A (en) Process for sterilization with liquid sterilant using controlled pumpdown rate
AU2002301749B2 (en) Apparatus and process for concentrating a sterilant and sterilizing articles therewith
US6528016B1 (en) Method for rapidly determining the acceptability of loads to be sterilized
US20030017074A1 (en) Sterilizing a device by revaporizing a condensed vapor
JP2006110349A (en) Sterilization system and method and orifice inlet control apparatus therefor
US5804139A (en) Two-step sterilization process using liquid sterilant
US6010662A (en) Two-step sterilization process using liquid sterilant
US20130236359A1 (en) Methods for sterilization in a vacuum system

Legal Events

Date Code Title Description
STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION